RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Pediatric Patients with Attention Deficit/Hyperactivity Disorder
RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Pediatric Patients with Attention Deficit/Hyperactivity Disorder
批准号:
10760442
负责人:
CODY GREGORY FELTCH
金额:
$48.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-01 至 2024-08-31
关键词:
Academic achievementAcademyAddressAlgorithmsAmericanAnkleAttention deficit hyperactivity disorderBiological MarkersBreakthrough deviceCaregiver BurdenCaregiversChildChildhoodClinicalClinical TrialsCommunicationDataDevicesDiagnosisEconomic BurdenEconomicsEmotionalEnsureExpenditureFamilyFeelingFinancial HardshipFundingFutureGeneral PopulationGenerationsGoalsHealthHyperactivityImpulsivityIncidenceIndividualIndustrializationIronLaboratoriesLegLongitudinal StudiesMarketingMeasurementMeasuresMedicalMedicineMental disordersMethodsMovementOccupationalOralPainParticipantPatientsPediatricsPerformance at workPeriodicalsPhasePolysomnographyPopulationPrevalenceQuality of lifeReportingRestless Legs SyndromeScheduleSleepSleep DisordersSleep disturbancesSmall Business Innovation Research GrantSymptomsSystemTechnologyTestingUnited States Food and Drug Administrationaccurate diagnosisaffective disturbancecomorbiditydesigndiagnostic valueimprovedimproved outcomeinattentionindexingiron supplementationmobile applicationnovelpediatric patientspoor sleepsensorusabilityverbalwearable device
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
Millions of pediatric patients with attention-deficit/hyperactivity disorder (ADHD) suffer from sleep disturbances
that significantly degrade their quality of life and amplifies the heavy emotional and financial burden on
caregivers. Restless Legs Syndrome (RLS) is a likely (and treatable) factor for the sleep disturbance in these
patients. Oral iron therapy has been shown to improve both sleep and ADHD symptoms in children. However,
RLS is currently difficult to diagnose, particularly in pediatric patients with ADHD. The diagnosis is made clinically
with subjective, patient reports and the symptoms themselves are variable across individuals. Thus, patients with
ADHD who may already have difficulty with verbal expression are especially vulnerable to being misdiagnosed.
RestEaze is an ankle-worn wearable technology and mobile application developed by Tanzen Medical Inc. to
measure leg movements during sleep that are highly related to RLS and can serve as an objective biomarker of
the condition. The device is industrially designed to be comfortably worn by the patient and washable to permit
extended, nightly use. The mobile application is easy to use by the patient (or caregiver) to interact with and
store data from the device. The read-out provided to the clinician provides clear, actionable information that
quantifies the patients’ leg movements during sleep in reference to American Academy of Sleep Medicine
standards. In sum, RestEaze directly addresses a significant unmet medical need by providing a technology
that can substantially improve the diagnosis and subsequent management of RLS in pediatric patients with
ADHD. The use of this technology is expected to improve the quality of life for patients with ADHD and their
caregivers by directly addressing their sleep disturbance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金